key: cord-0767765-umm2sqc7 authors: Lee, Wen-Ling; Kuo, Shu-Chen; Wang, Peng-Hui title: Pregnant women with COVID-19 date: 2022-02-10 journal: Taiwan J Obstet Gynecol DOI: 10.1016/j.tjog.2022.02.003 sha: e35b5b99a2c4a5d47a31b6a5f893c47a89e07d6b doc_id: 767765 cord_uid: umm2sqc7 nan the real-world experience in the management of pregnant women with SARS-CoV-2 infection is of urgent need and paramount importance. Therefore, we are happy to introduce one article entitled "perinatal outcomes of pregnant women having SARS-CoV-2 infection" published in the last issue in 2021 of the Taiwanese Journal of Obstetrics and Gynecology, which explored this topic [11] . Dr. Arzu Arinkan and colleagues conducted a prospective observation study to evaluate the outcome of pregnant women with SARS-CoV-2 infection and further compare the difference of perinatal outcome of pregnant women with (n=46) and without (n=70) SARS-CoV-2 infection [11] . Among the SARS-CoV-2 infected pregnant women, 5, 13 and 28 women occurred in the first, second, and third trimester, respectively. The symptoms included cough (42.3%), dyspnea (26.2%), myalgia (15.2%), fever (8.7%), and loss of taste, fatigue or diarrhea (2.2%), respectively. Two-thirds of pregnant women were hospitalized. It is interesting to find that no statistically significant difference of delivery week, newborn weight, Apgar scores (at one or five minute) was found between pregnant women with and without SARS-CoV-2 infection. The current study is interesting and worthy of further discussion. J o u r n a l P r e -p r o o f 4 First, as shown by authors, 40% (2/5) of the first trimester pregnancies complicated with SARS-CoV-2 infection were ended by abortion [11] . Although the case number is extremely small, the question about the relationship between SARS-CoV-2 infection and risk of abortion is raised. Based on the Dr. Arzu Arinkan's study [11] , the risk of abortion seemed to be increased in the first trimester. To respond to this question, a recent systematic review may give us some hints. According to the summary of 11 studies, the authors found that there is an increased risk of abortion with SARS-CoV-2 infection, which several case reports and case series, have identified during the pandemic [12] . Additionally, studies related to abortion in pregnant women with SARS-CoV-2 infection show that most of abortions due to SARS-CoV-2 infection in the first trimester were due to placental insufficiency [12] . This placental insufficiency can by supported by finding the deposition of perivillous fibrin and multiple villous infarcts in the placenta in pregnant women with SARS-CoV-2 infection [12] . Another etiology for abortion in the first trimester may be secondary to the inflammatory events, although these may not be always involved in placenta directly [12] . However, the association between SARS-CoV-2 infection and abortion is not always reproducible, and the results from the studies are conflicted. We suppose this uncertainty may be related to severity of the diseases, since in nonhospitalized pregnant women with SARS-CoV-2 infection did not significantly differ in nuchal translucency thickness and double test in the first trimester screening as well as there was no significantly increased risk of abortion in these subjects [12] . All hint us that the association between abortion and SARS-CoV-2 infection needs more studies to clarify their relationship. Second, in the current study, management of pregnant women with SARS-CoV-2 infection regardless of hospitalization or not is worthy of discussion. The therapeutic agents were varied greatly, including 30.4% (n=14) with hydroxycloroquine, 17% (n=8) with kaletra (50mg ritonavir plus 200mg lopinavir), 10 .9% (n=4) with favipiravir, 2.3% (n=1) with hydroxycloroquine plus favipiravir, and 39.1% (n=18) without any aforementioned treatment [11] . Among these patients, In summary, as shown above, evidence-based knowledge about pregnant women with SARS-CoV-2 infection is still limited. We are looking forward to learning more and more articles focusing on this population who are vulnerable to infection pandemic. All authors declare no conflict of interest. A symptomatic nearterm pregnant woman recovered from SARS-CoV-2 infection Maternal and fetal outcomes of the pregnant woman with COVID-19: The first case report in Taiwan Relationship of COVID-19 with pregnancy The impact of COVID-19 in pregnancy: Part II. Vaccination to pregnant women Clinical manifestation and disease progression in COVID-19 infection Coronavirus Disease-19 Dashboard The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19 The precaution strategy toward the COVID-19 pandemic in the operating room of a tertiary hospital in Taiwan Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients Perinatal outcomes of pregnant women having SARS-CoV-2 infection COVID-19 and cause of pregnancy loss during the pandemic: A systematic review Information for healthcare professionals. Coronavirus (COVID-19) infection in pregnancy Therapeutic management of hospitalized adults with COVID-19. COVID-19 Treatment Guidelines Panel Treatment Guidelines Dexamethasone in hospitalized patients with covid-19 Pandemic aspect of dexamethasone: Molecular mechanisms and clinical application